News

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D

For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, according to a study published online Nov. 27 in eClinicalMedicine. Fumiki Yoshihara, from the National Cerebral and Cardiovascular Center in Osaka, Japan, and colleagues conducted a multicenter, randomized trial that enrolled

tDCS Promising for Improved Cognition in Alzheimer’s

TOPLINE: Transcranial direct current stimulation (tDCS) delivered twice daily over 6 weeks can improve cognitive function in patients with Alzheimer’s disease (AD), highlighting the potential of tDCS as a therapeutic intervention, new research shows.  METHODOLOGY: The study enrolled 124 patients with mild to moderate AD, with 63 randomly allocated to receive active tDCS and 61

Study to Examine Routine ICD Implantation Post Heart Attack

PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of Cardiology is a partner in this large-scale trial. Implantable Cardioverter Defibrillators (ICDs) Heart attack survivors are at an increased risk for death…

ECG Deep-Learning Algorithm Predicts Mortality Post Surgery

TOPLINE: An artificial intelligence (AI) deep-learning algorithm interpreting preoperative ECGs can identify risk for postoperative death in those undergoing cardiac surgery, noncardiac surgery, and interventional procedures, a large new study showed. The algorithm was more effective in identifying high-risk patients who went on to experience postoperative mortality than a widely used risk tool…

Passing of Dr Jean-Philippe Collet

Jean-Philippe Collet, MD, head of medical cardiology at Pitié-Salpêtrière Hospital, Paris, France, passed away suddenly on Friday, December 15, at the age of 59 years. The cardiology community, still in shock, mourns the loss. Dr Jean-Philippe Collet “Cardiology loses a genius, and patients lose a beloved doctor…He was a mentor to us all…